USPTO 2015–2025 USPTO PatentsView US Corporation

Bionx Medical Technologies, Inc.

USPTO PatentsView assignee record - 20 granted patents across 9 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Bionx ranks #14,496 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 9 technology areas.

#14,496
of 49,997 US assignees by volume
41st percentile
by Innovation Score (32.4/100)
18.9
avg claims per patent
-82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14496 · US Corporation #14,496 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 20 grants
  • MID-PACK #14,496/49,997
  • PHOTO-FINISH Beijing Oceanbase…
  • CPC-NARROW A61F · 9 areas
  • INNOV-THIN 32.4/100
  • CLAIMS-RICH 18.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -82% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beijing Oceanbase Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bionx’s 32.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Bionx

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Bionx's Innovation Score is 32.4/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Bionx?

Each dot is one of Bionx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bionx’s own 18.9 claims/patent is ABOVE the 10.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bionx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 19.919.92020.1 0510152025 Granted patents (volume) Avg claims / patent Beijing Oceanbase Technology Co., Ltd. - 20, 17.9Beijing Oceanbase…Bejo Zaden B.V. - 20, 7.55Bejo Zaden B VBell & Ross B.V. - 20, 1Bell & Ross B VBenteler Steel/Tube GmbH - 20, 16.2Benteler Steel/Tu…Biotech Institute, LLC - 20, 10.5Biotech InstituteBirdie Biopharmaceuticals, Inc. - 20, 23.7Birdie Biopharmac…Bormioli Luigi S.p.A. - 20, 4.45Bormioli Luigi S…Braeburn Systems LLC - 20, 13.1Braeburn SystemsBionx Medical Technologies, Inc. - 20, 18.85Bionx Medical
Bionx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bionx's grants concentrate

Bionx Medical Technologies, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2016. By volume, Bionx sits between Beijing Oceanbase Technology Co., Ltd. and Braeburn Systems LLC.

Who files at Bionx's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Bionx holds 20 patents at rank #14,502, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Bionx

By rank, the assignees closest to #14,502 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Bionx's primary technology class.

Bionx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20162017201820192020 3
USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Bionx Medical Technologies, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 5.0%
2017 6 30.0%
2018 5 25.0%
2019 5 25.0%
2020 3 15.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Bionx Medical Technologies, Inc.'s patent record in context - here's where to go next.

  • Bionx Medical Technologies, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #14,496 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Bionx Medical Technologies, Inc. against Beijing Oceanbase Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 32.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.